公司资料
Navidea 股价、新闻与催化剂
- 股票代码:
- NAVB
- 交易所:
- AMEX
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for NAVB.
公司概览
业务概览
Navidea Biopharmaceuticals is a biotechnology company that has historically focused on diagnostic and targeted molecular imaging approaches. Its story reflects the difficulty of sustaining a narrow clinical and commercial platform over time.
所在地与行业分类
Navidea is headquartered in the United States and listed on NYSE American. It sits in small-cap biotech and medical imaging-adjacent therapeutics.
商业模式特征
The company depends on corporate restructuring, financing, and the ability to preserve value in a very narrow asset set. Investors historically watched regulatory developments and strategic shifts.
生物医药行业定位
Navidea occupies a legacy small-cap biotech niche. The stock has long been driven more by capital structure and survival than by broad commercial scale.
未来催化剂
- Navidea is now mostly a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update rather than a live diagnostic milestone. The market is focused on what remains.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。